Selected research
Industry Research
Animal-derived Immune Globulin Products Industry Research Report 2026
Market perspective
The global Animal-derived Immune Globulin Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal-derived Immune Globulin Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal-derived Immune Globulin Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal-derived Immune Globulin Products include Sanofi, Merck & Co, Pfizer, Rare Disease Therapeutics, BTG Specialty Pharmaceuticals and Bioclon Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal-derived Immune Globulin Products market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal-derived Immune Globulin Products Market by Company
Sanofi
Merck & Co
Pfizer
Rare Disease Therapeutics
BTG Specialty Pharmaceuticals
Bioclon Institute
Animal-derived Immune Globulin Products Segment by Type
IVIg Liquid
IVIg Powder
Animal-derived Immune Globulin Products Segment by Application
Autoimmune Disease
Immunodeficiency
Acute Infection
Animal-derived Immune Globulin Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal-derived Immune Globulin Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal-derived Immune Globulin Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IVIg Liquid
- IVIg Powder
Applications
- Autoimmune Disease
- Immunodeficiency
- Acute Infection
Companies covered
- Sanofi
- Merck & Co
- Pfizer
- Rare Disease Therapeutics
- BTG Specialty Pharmaceuticals
- Bioclon Institute
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal-derived Immune Globulin Products Market Size (2021-2032)
- 2.2.2 Global Animal-derived Immune Globulin Products Sales (2021-2032)
- 2.2.3 Global Animal-derived Immune Globulin Products Market Average Price (2021-2032)
- 2.3 Animal-derived Immune Globulin Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 IVIg Liquid
- 2.3.3 IVIg Powder
- 2.4 Animal-derived Immune Globulin Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Autoimmune Disease
- 2.4.3 Immunodeficiency
- 2.4.4 Acute Infection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal-derived Immune Globulin Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal-derived Immune Globulin Products Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Animal-derived Immune Globulin Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal-derived Immune Globulin Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal-derived Immune Globulin Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal-derived Immune Globulin Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal-derived Immune Globulin Products, Product Type & Application
- 3.8 Global Manufacturers of Animal-derived Immune Globulin Products, Established Date
- 3.9 Global Animal-derived Immune Globulin Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Animal-derived Immune Globulin Products Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Merck & Co
- 4.2.1 Merck & Co Company Information
- 4.2.2 Merck & Co Business Overview
- 4.2.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co Animal-derived Immune Globulin Products Product Portfolio
- 4.2.5 Merck & Co Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Animal-derived Immune Globulin Products Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Rare Disease Therapeutics
- 4.4.1 Rare Disease Therapeutics Company Information
- 4.4.2 Rare Disease Therapeutics Business Overview
- 4.4.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio
- 4.4.5 Rare Disease Therapeutics Recent Developments
- 4.5 BTG Specialty Pharmaceuticals
- 4.5.1 BTG Specialty Pharmaceuticals Company Information
- 4.5.2 BTG Specialty Pharmaceuticals Business Overview
- 4.5.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio
- 4.5.5 BTG Specialty Pharmaceuticals Recent Developments
- 4.6 Bioclon Institute
- 4.6.1 Bioclon Institute Company Information
- 4.6.2 Bioclon Institute Business Overview
- 4.6.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio
- 4.6.5 Bioclon Institute Recent Developments
5 Global Animal-derived Immune Globulin Products Market Scenario by Region
- 5.1 Global Animal-derived Immune Globulin Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal-derived Immune Globulin Products Sales by Region: 2021-2032
- 5.2.1 Global Animal-derived Immune Globulin Products Sales by Region: 2021-2026
- 5.2.2 Global Animal-derived Immune Globulin Products Sales by Region: 2027-2032
- 5.3 Global Animal-derived Immune Globulin Products Revenue by Region: 2021-2032
- 5.3.1 Global Animal-derived Immune Globulin Products Revenue by Region: 2021-2026
- 5.3.2 Global Animal-derived Immune Globulin Products Revenue by Region: 2027-2032
- 5.4 North America Animal-derived Immune Globulin Products Market Facts & Figures by Country
- 5.4.1 North America Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 5.4.3 North America Animal-derived Immune Globulin Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal-derived Immune Globulin Products Market Facts & Figures by Country
- 5.5.1 Europe Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 5.5.3 Europe Animal-derived Immune Globulin Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal-derived Immune Globulin Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal-derived Immune Globulin Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal-derived Immune Globulin Products Market Facts & Figures by Country
- 5.7.1 South America Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 5.7.3 South America Animal-derived Immune Globulin Products Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal-derived Immune Globulin Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal-derived Immune Globulin Products Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal-derived Immune Globulin Products Sales by Type (2021-2032)
- 6.1.1 Global Animal-derived Immune Globulin Products Sales by Type (2021-2032) & (units)
- 6.1.2 Global Animal-derived Immune Globulin Products Sales Market Share by Type (2021-2032)
- 6.2 Global Animal-derived Immune Globulin Products Revenue by Type (2021-2032)
- 6.2.1 Global Animal-derived Immune Globulin Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal-derived Immune Globulin Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal-derived Immune Globulin Products Sales by Application (2021-2032)
- 7.1.1 Global Animal-derived Immune Globulin Products Sales by Application (2021-2032) & (units)
- 7.1.2 Global Animal-derived Immune Globulin Products Sales Market Share by Application (2021-2032)
- 7.2 Global Animal-derived Immune Globulin Products Revenue by Application (2021-2032)
- 7.2.1 Global Animal-derived Immune Globulin Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal-derived Immune Globulin Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal-derived Immune Globulin Products Value Chain Analysis
- 8.1.1 Animal-derived Immune Globulin Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal-derived Immune Globulin Products Production Mode & Process
- 8.2 Animal-derived Immune Globulin Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal-derived Immune Globulin Products Distributors
- 8.2.3 Animal-derived Immune Globulin Products Customers
9 Global Animal-derived Immune Globulin Products Analyzing Market Dynamics
- 9.1 Animal-derived Immune Globulin Products Industry Trends
- 9.2 Animal-derived Immune Globulin Products Industry Drivers
- 9.3 Animal-derived Immune Globulin Products Industry Opportunities and Challenges
- 9.4 Animal-derived Immune Globulin Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst